BRPI0516663A - bengamidas que possuem um ciclocaprolactama substituìdo, processo de preparo, composições que os contém e a utilização - Google Patents

bengamidas que possuem um ciclocaprolactama substituìdo, processo de preparo, composições que os contém e a utilização

Info

Publication number
BRPI0516663A
BRPI0516663A BRPI0516663-2A BRPI0516663A BRPI0516663A BR PI0516663 A BRPI0516663 A BR PI0516663A BR PI0516663 A BRPI0516663 A BR PI0516663A BR PI0516663 A BRPI0516663 A BR PI0516663A
Authority
BR
Brazil
Prior art keywords
compositions containing
preparation process
substituted
cyclocaprolactam
bengamides
Prior art date
Application number
BRPI0516663-2A
Other languages
English (en)
Inventor
Jidong Zhang
Neerja Bhatnagar
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BRPI0516663A publication Critical patent/BRPI0516663A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

BENGAMIDAS QUE POSSUEM UM CICLOCAPROLACTAMA SUBSTITUìDO, PROCESSO DE PREPARO, COMPOSIçõES QUE OS CONTêM E A UTILIZAçAçãO. A presente invenção refere-se a caprolactamas substituídos, Processo de preparo, composições que os contêm e utilização. A presente invenção refere-se notadamente ao preparo de caprolactamas substituídas, ao respectivo preparo, às composições que os contêm, e à respectiva utilização como medicamento, em particular como agentes anticancerígenos.
BRPI0516663-2A 2004-11-29 2005-11-25 bengamidas que possuem um ciclocaprolactama substituìdo, processo de preparo, composições que os contém e a utilização BRPI0516663A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0412646A FR2878525B1 (fr) 2004-11-29 2004-11-29 Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
PCT/FR2005/002931 WO2006056695A1 (fr) 2004-11-29 2005-11-25 Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation

Publications (1)

Publication Number Publication Date
BRPI0516663A true BRPI0516663A (pt) 2008-09-16

Family

ID=34954085

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516663-2A BRPI0516663A (pt) 2004-11-29 2005-11-25 bengamidas que possuem um ciclocaprolactama substituìdo, processo de preparo, composições que os contém e a utilização

Country Status (17)

Country Link
US (2) US20070249584A1 (pt)
EP (1) EP1819680B1 (pt)
JP (1) JP2008521779A (pt)
KR (1) KR20070089723A (pt)
CN (1) CN101065361A (pt)
AR (1) AR052035A1 (pt)
AT (1) ATE545632T1 (pt)
AU (1) AU2005308709A1 (pt)
BR (1) BRPI0516663A (pt)
CA (1) CA2585990A1 (pt)
FR (1) FR2878525B1 (pt)
IL (1) IL183189A0 (pt)
MX (1) MX2007006042A (pt)
PE (1) PE20061081A1 (pt)
RU (1) RU2007123394A (pt)
TW (1) TW200630342A (pt)
WO (1) WO2006056695A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153846B2 (en) * 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
FR2878528B1 (fr) * 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2878525B1 (fr) * 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2901556A1 (fr) * 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
FR2901555A1 (fr) * 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) * 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
GB2451451A (en) * 2007-07-30 2009-02-04 Inion Ltd Osteogenic compounds
CN101456824B (zh) * 2007-12-11 2013-04-17 中国科学院上海药物研究所 α-氨基-N-取代酰胺化合物、包含该化合物的药物组合物及其用途
CN102911118B (zh) * 2012-11-09 2014-04-09 天津商业大学 一类苯并氮杂卓类衍生物及其制备方法和用途
CN109320456A (zh) * 2018-11-16 2019-02-12 天津商业大学 新晶型的抗肿瘤化合物及其制备方法和含其的组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692522A (en) * 1985-04-01 1987-09-08 Merck & Co., Inc. Benzofused lactams useful as cholecystokinin antagonists
US4831135A (en) * 1986-06-18 1989-05-16 The Regents Of The University Of California Bengamide anthelmintics
US5283241A (en) * 1992-08-28 1994-02-01 Merck & Co., Inc. Benzo-fused lactams promote release of growth hormone
GB9411841D0 (en) 1994-06-14 1994-08-03 Pharma Mar Sa New antitumoral compounds from jaspis sponge
JP2002241368A (ja) 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
US6239127B1 (en) * 1999-11-17 2001-05-29 Novartis Ag Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation
CO5140099A1 (es) * 1998-11-17 2002-03-22 Novartis Ag Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
CN1191237C (zh) 2000-05-11 2005-03-02 诺瓦提斯公司 取代的己内酰胺碳酸酯与醚和它们作为抗肿瘤剂的用途
EP1337854A2 (en) 2000-11-14 2003-08-27 Novartis AG Method for screening anti-proliferative compounds and inhibiting tumor growth
US6545148B2 (en) * 2001-03-12 2003-04-08 Novartis Ag Process for preparing certain substituted caprolactams
JP2004262793A (ja) * 2003-02-28 2004-09-24 Noyaku Bio Technology Kaihatsu Gijutsu Kenkyu Kumiai 化合物ｎ−９０１１、その製造法及び用途
BRPI0412843A (pt) * 2003-07-25 2006-09-26 Novartis Ag lactamas substituìdas e uso das mesmas como agentes anticáncer
DE10349669B3 (de) * 2003-10-24 2005-05-25 Aventis Pharma Deutschland Gmbh Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US7153846B2 (en) * 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
FR2878525B1 (fr) * 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2878528B1 (fr) 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
US20090007597A1 (en) * 2007-07-02 2009-01-08 Hanevold Gail F Body attached band with removal visual image pockets

Also Published As

Publication number Publication date
WO2006056695A8 (fr) 2007-04-05
CA2585990A1 (fr) 2006-06-01
FR2878525B1 (fr) 2007-02-23
US7585855B2 (en) 2009-09-08
EP1819680B1 (fr) 2012-02-15
EP1819680A1 (fr) 2007-08-22
FR2878525A1 (fr) 2006-06-02
ATE545632T1 (de) 2012-03-15
PE20061081A1 (es) 2006-12-08
AR052035A1 (es) 2007-02-28
US20070249584A1 (en) 2007-10-25
KR20070089723A (ko) 2007-08-31
CN101065361A (zh) 2007-10-31
JP2008521779A (ja) 2008-06-26
WO2006056695A1 (fr) 2006-06-01
AU2005308709A1 (en) 2006-06-01
MX2007006042A (es) 2007-07-10
IL183189A0 (en) 2007-08-19
RU2007123394A (ru) 2009-01-10
US20080318928A1 (en) 2008-12-25
TW200630342A (en) 2006-09-01

Similar Documents

Publication Publication Date Title
UY28662A1 (es) Agente endoparasiticida para administracion topica
UY31080A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
BR112012007102A2 (pt) compostos policíclicos como antagonistas de receptores do ácido lisofosfatpidico
CL2007002635A1 (es) Compuestos derivados de quinazolinona e isoquinolinona, moduladores de la actividad del eje hpa; composicion farmaceutica que los comprende; y su uso en el tratamiento y/o prevencion relacionado con estres o depresion.
CR10247A (es) Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica
BRPI0512352A (pt) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimiocinas
AR062162A1 (es) Una composicion del factor vii recombinante o transgenico que exhibe principalmente formas de glicano no fucosilado bisialilado y biantenario
BRPI0606761A2 (pt) pirróis e imidazóis substituìdos, composições que os contêm, processo de produção e utilização
BRPI0516663A (pt) bengamidas que possuem um ciclocaprolactama substituìdo, processo de preparo, composições que os contém e a utilização
BR112015002464B8 (pt) processo para a preparação de carbamat-benzoxazinona, carbamat-benzoxazinona e uso da carbamat-benzoxazinona
CL2011002617A1 (es) Compuestos derivados de arilsulfonamidas 2,5-disustituidas, moduladores del receptor ccr3; composicion farmaceutica que los comprende; y uso del compuesto o de la composicion para prevenir y/o tratar un trastorno inflamatorio o inmunoregulador tal como asma, rinitis, vih, enfermedad de alzheimer, entre otros.
BRPI1100012A2 (pt) agente para realçar a expressão de fatores associados com redox
BRPI0516666A (pt) 2-alcóxi-3,4,5-trihidróxi-alquilamidas, o respectivo preparo, composições que as contém e a respectiva utilização
BRPI0702573A8 (pt) Sílicas precipitadas que têm propriedades de superfície especiais
BRPI0908569B8 (pt) estimuladores de secreção de insulina derivados de piridopirazinonas, seu uso, e composição farmacêutica
CR9231A (es) Pirroles sustituidos, composiciones que los contienen, procesos de fabricacion y utilizacion
DOP2006000015A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricación
BR112022005068A2 (pt) Compostos antibacterianos de 4-quinolinona
BR112022005449A2 (pt) Compostos antibacterianos
BRPI0717453A2 (pt) Derivados indólicos, o respectivo processo de preparo e as composições farmacêuticas que os contêm
ECSP088893A (es) 2-alcoxi-3, 4,5-trihidroxi-alquilamida-benzazepinas, su preparación, composiciones que las contienen y utilización
ECSP088899A (es) Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparación, composiciones que las contienen y utilización
ECSP088897A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparación, composiciones que las contienen y utilización
BRPI0519141A2 (pt) processo para e intermediÁrios na preparaÇço de canfosfamida e dos sais das mesmas, composiÇÕes farmacÊuticas contendo alguns intermediÁrios e o uso do mesmo como agentes anticÂncer
BRPI0515811A (pt) indóis substituìdos, processo para preparação, bem como utilização dos mesmos, medicamento e composição farmacêutica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.